Egis in the World

Our products reach 100 countries

Click here to learn more

Pharma Company

Our activities incorporate all areas of the pharmaceutical value chain

Click here to learn more

Research & Development

Innovation is one of the pillars of our strategy. We devoted EUR 48 million to research and development in the 2022/2023 financial year.

Click here to learn more
Egis World Pharma Company R&D
Own subsidiaries / Representative offices
Sales through Partners
Corporate Social Responsibility

«Egis eco-marathon» is recognized as one of the best ESG projects in Russia

More
Corporate Social Responsibility

The program «Ferritin-2023» is recognized as the best medical-social project of Russia

On June 13 the results of the XII Program «The Best Social Projects of Russia» were summed up. The patient support program «Ferritin-2023» of the pharmaceutical company «EGIS-RUS» was recognized as the best in the category of «Medical-social projects». The Program Board of Experts highly appreciated the significance of the project for society and its role in the development of the company’s social ecosystem in Russia.

More
Innovation

Egis' medicines won the Innovation Grand Prize

Two of Egis’ fixed-dose combination drugs have won the Innovation Grand Prize. The awarded Egis medicines feature significant innovations as they reduce the risk of cardiovascular events related to atherosclerosis due to the combined lipid-lowering therapy. In respect of these two products the company obtained three patents related to active ingredient development and two patents related to formulation development that are all relevant to large-scale manufacturing technologies. The recognition was not without a history, as this is the tenth time an Egis medicine has received an Innovation Prize or Grand Prize.

More
More articles

Egis in the World

Egis' products are sold to 100 countries.

Egis’ products reach countries. Our portfolio consists of 653 products.  Our main focus lies on treating diseases of the cardiovascular and central nervous systems.

Learn more

Place to work

Join us!

Learn more

Healthcare Professionals

and prescription drugs

Professional content for our medical and pharmaceutical visitors. The information in this section is for healthcare specialists only!

Learn more
Therapic areas
Therapic areas
Allergology
Cardiovascular system
Central nervous system
Women´s health
Dermatology

Gallery

Downloads

Our related products

More
Quick news
Feb 21.

New features of the Neuroscanner mobile app will help doctors diagnose dementia and depression

At the symposium "In the gloomy Forest of Neurology and Psychiatry", which was held on February 20, 2024 as part of the "Vein's Readings", the level of diagnosis of affective, neurodegenerative and autonomic disorders was discussed.
More
Apr 16.

"Science against allergies": new advertising campaign of Suprastinex®

At the early allergy season, "EGIS-RUS" reminds that innovations help to resist typical triggers of allergy. A new advertising campaign of the antihistamine Suprastinex ® started in April on the air of the largest Russian federal channels.
More
Feb 09.

Egis reminds what protection you need in case of acute and sudden allergies

The Commercial "Just in case of allergy" is broadcast on the air of the largest federal television channels: TNT, NTV, Domashny, Channel Five, RenTV, TV-3, Yu, MuzTV, as well as on the Internet.
More
Nov 29.

Winter advertising campaign of NOVATENOL®

Winter seasonal TV advertising of NOVATENOL® is based on a series of cozy winter stories from the life of a family: walks in a snow-covered park, sledding, holiday in the countryside. NOVATENOL® helps to forget unpleasant moments and keep in memory only wonderful memories, regenerating and moisturizing your skin while you spend time with your family.
More
Apr 28.

"Allergy is no longer a nightmare" -a new TV commercial from Suprastin® and Suprastinex® has released

The creators of the TV commercial EGIS-RUS and the creative agency Havas Creative Group Russia, used the popular genre  of thriller based on, perhaps, the most  common fear among patients with allergy which is associated with a painful expectation of strongest allergy symptoms, filling all around and no longer allowing to relax for a second. Ordinary situations like an open window or a contact with a kitten - can turn your life into a real horror movie.
More
Apr 19.

"BETADIN®. There is no reason to stop": the advertising campaign of the universal antiseptic agent is again on TV broadcast.

Good weather in the spring-summer period is conducive to active games on the street, however, at the same time, it increases the risk of injury, which is impossible to insure against. The question of choosing first aid remedy is becoming especially relevant. "EGIS-RUS" has released a TV commercial talking about the delicate action of the antiseptic BETADIN®.
More

Principles of Pharmacovigilance

Please report any adverse events

Click here
Play video
Show gallery
flag
No. of employees
No. of products
Subsidiary/representation was established in
flag
No. of employees
No. of products
Subsidiary/representation was established in

Play video
Show gallery

Play video

Gallery

Downloads

Our related products

Cookie Settings

Egis’s website uses cookies to run our website, improve the user experience and monitor the activities. You can customize the use of the cookies by adapting the settings.

Cookies necessary for basic functioning

These cookies ensure the appropriate functioning of the website, facilitate its use and collect information on its use without identifying visitors.

Functional cookies

In order to enhance the user experience, we use cookies which record the use of certain functions of the website, thus enabling users to have the same settings at the time of their next visit.

Cookies for statistical purposes

They provide statistical data on the performance of the website (such as number of page loads, average time spent on the website) in order to collect data for the operator of the website on the website usage patterns of users. These cookies do not identify visitors, information collected by them relate to the number of subpages visited by the user, the length of each session, the types of error messages, etc. Cookies for statistical purposes are automatically placed on the user’s devices during browsing, and you can delete such cookies in the browser settings.
Details
I Agree
WarningYour browser is out of date. Please, use an updated version! Chrome || Firefox